Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence
- PMID: 30640897
- PMCID: PMC6331102
- DOI: 10.1371/journal.pone.0208610
Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence
Abstract
Background: Lung cancer is the most common adult malignancy accounting for the largest proportion of cancer related deaths. Iron (Fe) is an essential trace element and is a component of several major metabolic pathways playing an important role in many physiological processes. In this study we evaluated the association between Fe concentration in serum, iron metabolism parameters and genetic variaton in 7 genes involved in iron metabolism and anti-oxidative processes with the incidence of lung cancer in Poland.
Materials and methods: The study included 200 lung cancer patients and 200 matched healthy control subjects. We analyzed serum iron concentration and iron metabolism parameters (TIBC, UIBC, serum ferritin and transferrin saturation), and genotyped seven variants in seven genes: HFE, TFR1, HAMP, TF, SOD2, CAT and GPX1.
Results: Lung cancer patients compared to their matched controls had significantly higher mean serum iron level (p = 0.01), ferritin level (p = 0.007) and TIBC (p = 0.006). Analysis revealed that higher concentration of iron and ferritin (IVth quartile) compared to the lower concentration (Ist quartile) was associated with over 2-fold increased lung cancer incidence. We also found that higher transferrin saturation (p = 0.01) and lower TIBC (p<0.01) are associated with better survival of lung cancer patients. The analysis of polymorphisms in iron related genes did not reveal a significant difference between lung cancer patients and controls. However, rs10421768 in HAMP showed a borderline statistically significant correlation with lung cancer risk (OR = 2.83, p = 0.05).
Conclusions: The results of this case control study indicate that higher body iron represented by higher Fe and ferritin levels may be associated with lung cancer incidence. Rs10421768 in HAMP may be associated with about 3-times higher lung cancer risk. Higher Fe body content may be associated with better survival of lung cancer patients.
Conflict of interest statement
The authors have read the journal's policy and have the following conflicts: The authors WM, MM, and JL are employed by Read-Gene S.A.; SG is employed by Strand Life Sciences; and PW is employed by an Independent Laboratory of Pathology. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products to declare.
Similar articles
-
Serum folate concentration and the incidence of lung cancer.PLoS One. 2017 May 11;12(5):e0177441. doi: 10.1371/journal.pone.0177441. eCollection 2017. PLoS One. 2017. PMID: 28493936 Free PMC article.
-
Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer.Med Oncol. 2010 Jun;27(2):268-77. doi: 10.1007/s12032-009-9203-2. Epub 2009 Mar 24. Med Oncol. 2010. PMID: 19308738
-
Transferrin types, iron-binding capacity and body iron stores.Hum Hered. 1993 Nov-Dec;43(6):337-41. doi: 10.1159/000154156. Hum Hered. 1993. PMID: 8288264
-
Total iron binding capacity and transferrin concentration in the assessment of iron status.Clin Chem Lab Med. 2002 Oct;40(10):1014-8. doi: 10.1515/CCLM.2002.176. Clin Chem Lab Med. 2002. PMID: 12476940 Review.
-
Cellular Iron Metabolism and Regulation.Adv Exp Med Biol. 2019;1173:21-32. doi: 10.1007/978-981-13-9589-5_2. Adv Exp Med Biol. 2019. PMID: 31456203 Review.
Cited by
-
Depletion of Labile Iron Induces Replication Stress and Enhances Responses to Chemoradiation in Non-Small-Cell Lung Cancer.Antioxidants (Basel). 2023 Nov 15;12(11):2005. doi: 10.3390/antiox12112005. Antioxidants (Basel). 2023. PMID: 38001858 Free PMC article.
-
Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity.Cancer Med. 2020 May;9(10):3537-3550. doi: 10.1002/cam4.2982. Epub 2020 Mar 16. Cancer Med. 2020. PMID: 32176452 Free PMC article.
-
A narrative review of mechanisms of ferroptosis in cancer: new challenges and opportunities.Ann Transl Med. 2021 Oct;9(20):1599. doi: 10.21037/atm-21-4863. Ann Transl Med. 2021. PMID: 34790805 Free PMC article. Review.
-
Prognostic Significance of Iron Metabolism Related Genes in Human Lung Adenocarcinoma.Cancer Manag Res. 2023 Feb 22;15:203-216. doi: 10.2147/CMAR.S398982. eCollection 2023. Cancer Manag Res. 2023. PMID: 36860893 Free PMC article.
-
An Iron Metabolism-Related SLC22A17 for the Prognostic Value of Gastric Cancer.Onco Targets Ther. 2020 Dec 14;13:12763-12775. doi: 10.2147/OTT.S287811. eCollection 2020. Onco Targets Ther. 2020. PMID: 33363382 Free PMC article.
References
-
- Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, et al. SEER Cancer Statistics Review, 1975–2014, National Cancer Institute; Bethesda, MD, https://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017.
-
- Shen H, Wei Q, Pillow PC, Amos CI, Hong WK, Spitz MR. Dietaryfolate intake and lung cancer risk in former smokers: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2003;12(10):980–986. - PubMed
-
- Lipiński P, Starzyński RR, Gajowiak A, Staroń R, Styś A. Metabolizm żelaza- stan wiedzy 2014. Kosmos. 2014; 63(304):299–308.
-
- Knekt P, Reunanen A, Takkunen H, Aromaa A, Heliovaara M, Hakulinen T. Body iron stores and risk of cancer. Int J Cancer. 1994;56:379–382. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous